Novadip
3 known investors
Novadip develops a new class of regenerative tissue products aimed at accelerating the healing of large bone defects, bone non-union, and spine fusion in a single treatment. The company focuses on bone and tissue regenerative medicine for patients with critical bone defects, trauma, spinal conditions, and the rare congenital condition Congenital Pseudarthrosis of Tibia (CPT).
Investors · 3
In the news
Frequently asked questions
- What does Novadip do?
- Novadip develops a new class of regenerative tissue products aimed at accelerating the healing of large bone defects, bone non-union, and spine fusion in a single treatment. The company focuses on bone and tissue regenerative medicine for patients with critical bone defects, trauma, spinal conditions, and the rare congenital condition Congenital Pseudarthrosis of Tibia (CPT).
- Who are Novadip's investors?
- Novadip's investors include Fund+, New Science Ventures, VIVES Partners.